Comprehensive in vitro Proarrhythmia Assay (CiPA): Pending issues for successful validation and implementation.
about
Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs)Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?Composite Biomarkers Derived from Micro-Electrode Array Measurements and Computer Simulations Improve the Classification of Drug-Induced Channel Block.
P2860
Comprehensive in vitro Proarrhythmia Assay (CiPA): Pending issues for successful validation and implementation.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Comprehensive in vitro Proarrh ...... validation and implementation.
@ast
Comprehensive in vitro Proarrh ...... validation and implementation.
@en
Comprehensive in vitro Proarrhythmia Assay
@nl
type
label
Comprehensive in vitro Proarrh ...... validation and implementation.
@ast
Comprehensive in vitro Proarrh ...... validation and implementation.
@en
Comprehensive in vitro Proarrhythmia Assay
@nl
prefLabel
Comprehensive in vitro Proarrh ...... validation and implementation.
@ast
Comprehensive in vitro Proarrh ...... validation and implementation.
@en
Comprehensive in vitro Proarrhythmia Assay
@nl
P2093
P1476
Comprehensive in vitro Proarrh ...... validation and implementation.
@en
P2093
Henry Holzgrefe
Icilio Cavero
Jean-Frédéric Gerbeau
Jean-Michel Guillon
Mike Clements
Veronique Ballet
P356
10.1016/J.VASCN.2016.05.012
P577
2016-05-24T00:00:00Z